Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study

Document Type : Original Research Article


1 Department of Physiology, Shiraz University, Shiraz,Iran

2 Research Center for psychiatry and Behavior Science, Department of Psychiatry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran


Objectives: A correlation between hyperhomocysteinemia, and depression has been reported. Saffron (Crocus sativus) is recommended for treatment of depression; hence, in this study the effect of co-administration of saffron and fluoxetine on plasma homocysteine and depression was evaluated.
Material and methods: This was a 4-week randomized and double-blind clinical trial which was conducted from March 2013 to February 2014. In this trial, 40 male and females (20-55 years old) diagnosed with severe depression were selected and following filing the Beck form, were randomly divided into two groups.  Experimental group was treated with fluoxetine 20 mg/day and saffron 30 mg /day and the control group received placebo and fluoxetine 20 mg/day for four weeks. Before treatment and at the end of the study, fasting blood samples were collected. For females, blood samples were collected on the third day of their menstrual cycle.
Results: A significant reduction of homocysteine levels was observed in both sex in the experimental group compared to before treatment (p<0.04), while no such significant change was observed in the control group. A Beck questionnaire value showed lower level in both groups on the last day of treatment as compared to before treatment. There was no significant difference between the two groups in Beck value neither before nor after treatment.
Conclusion: Saffron has beneficial effects on depression and homocysteine level in patients with major depression.


Main Subjects

Abdullaev F I. 2002. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med, 227: 20–25.
Abe K, Saito H. 2000. Effects of saffron and its constituent crocin on learning behavior and long-term potentiation. Phytother Res, 14: 149-152.
Adongo DW, Kukuia KK, Mante PK, Ameyaw EO, Woode E. 2015. Antidepressant Like Effect of the Leaves of Pseudospondias microcarpa in Mice. BioMed Res Int, doi: 10.1155/397943.
Akhondzadeh S, Fallah Pour H, Afkham K, Jamshidi AH, Khalighi Cigarodi F. 2004. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression. BMC Comp Alt Med, 4: 12.
Allin S, Masseria C, Mossialos E. 2009. Measuring socioeconomic differences in use of health care services by wealth versus by income. Am J Public Health, 99: 1849-1855.
Bottiglieri T. 2005. Homocysteine and folate metabolism in depression. Prog NeuroPsychophermacol Biol Psychiatry, 29: 1103–1112.
Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MWP, Reynolds EH, 2000. Monoamine metabolism in depression. Psychol Med J, 69: 228–232.
Budge MM, De Jager C, Hogervorst E, Smith         AD, 2002. Memory TOPTI .Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc, 50:2014-2018.
Bukharaeva E, Shakirzyanova A, Khuzakhmetova V, Sitdikova G, Giniatullin R. 2015.  Homocysteine aggravates ROS-induced depression of transmitter release from motor nerve terminals . Frontiers Cell Neurosci, 9:391
Demyttenaere, K. 1997. Compliance during treatment with antidepressants.  J Affect Disord, 43:27-39.
Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF. 1997. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry, 154:426-8.
Hosseinzadeh H, Sadeghnia HR, Rahimi A. 2008. Effect of safranal on extracellular hippocampal levels of glutamate and aspartate during kainic acid treatment in anesthetized rats. Planta Med b, 74:1441–1445.
Holford P. 2003. Invited papers Depression the nutrition connection. Primary Care Mental Health, 1: 9– 16.
Khazdair MR, Boskabady MH, Hosseini M, Rezaee R, Tsatsakis A. 2015. Avicenna J Phytomed, 5:376-391. Review.
Koz ST, Etem EO, Baydas G, Yuce H, Ozercan HI, Kuloğlu T, Koz S, Etem A, Demir N. 2012. Effects of resveratrol on blood homocysteine level, on homocysteine induced oxidative stress, apoptosis and cognitive dysfunctions in rats.Brain Res, 1484:29-38.
 Lentz SR . 1997. Homocysteine and vascular dysfunction. Life sci, 61: 1205–1215
Lechtenberg MD, Schepmann M, Niehues N, Hellenbrand B, ¨unsch W, Hensel A. 2008. Quality and functionality of saffron: quality control, species assortment and affinity of extract and isolated saffron compounds to NMDA and σ 1(Sigma-1) receptors. Planta Medica, 74:764–772.
Li J, Qi Y, Liu H, Cui Y, Zhang L, Gong H, Li Y, Li L, Zhang Y. 2013. Acute high-altitude hypoxic brain injury: Identification of ten differential proteins.Neural Regen Res, 8:2932-41.
Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR, Stamler JS. 1997. Neurotoxicity associated with dual actions of homocysteine at the  N-methyl-D-aspartate receptor.Proc Natl Acad Sci U S A,94:5923-5928
MacDonald TM, Reid IC, McMahon AD. 1997. Patients receive an inadequate dose of antidepressants for an inadequate period BMJ, 315:56
Noorbala AA, Akhondzadeh S, Tamacebi-Pour N, Jamshidi AH, 2005. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial , J Ethnopharmacol, 97:281-284.
Nolen Hoeksema S, Girgus JS. 1994. The emergence of gender differences in depression during adolescence. Psychol Bull, 115: 424–443
Oldreive CE, Doherty GH. 2007. Neurotoxic effects of homocysteine on cerebellar Purkinje neurons in vitro. Neurosci Lett, 413:52-57.
Plante GE . 2005. Depression and cardiovascular disease: a reciprocal relationship. Metabolism Review, 54:45-48..
Rinki K, Agrawal A, Singh G. 2015. Dubey  Hyperhomocysteinemia as risk factor for depression: A review . Pharm Biol  Evalu, 2: 133-141
Rios JL, Recio MC, Giner RM, Manez S. 1996. An update review of saffron and its active constituents. Phytother Res, 10: 189–193.
Schildkraut JJ. 1965. J Neuropsychiatry Clin Neurosci. 7:524-533.
 Sachdev PS, Parslow RA, Lux O, Salonikas C, Wen W. 2005. Psychological medicine, 35: 529–538
Topić R, Aukst Margetić  B, Ćima  A, Štimac  Z, Jakovljević  M. 2010. P02-325 - Personality types A/B and D, cholesterol and homocystein in major depression compared to PTSD with and without depression European Psychiatry, 25: 1034
Tolmunen T, Hintikka J, Voutilainen S, Ruusunen A, Alfthan G. 2004. Association between depressive symptoms and serum concentrations of homocysteine in men: a population study.  Am j clinical nutrition, 80: 1574–1578
Waldmeier PC, Spooren WP, Hengerer B. 2000. Protects CGP 3466 dopaminergic neurons in lesion models of Parkinson's disease. Naunyn Schmiedebergs Arch Pharmacol, 362:526-537.